D
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A.,
“Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.”,
J Alzheimers Dis, 2015.
J. R. Gatchel, Donovan, N. J., Locascio, J. J., Schultz, A. P., J Becker, A., Chhatwal, J., Papp, K. V., Amariglio, R. E., Rentz, D. M., Blacker, D., Sperling, R. A., Johnson, K. A., and Marshall, G. A.,
“Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.”,
J Alzheimers Dis, vol. 59, no. 3, pp. 975-985, 2017.
B. Moon, Kim, S., Park, Y. Ho, Lim, J. - S., Youn, Y. Chul, Kim, S. Y., and Jang, J. - W.,
“Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1255-1264, 2017.
M. Barbera, Mangialasche, F., Jongstra, S., Guillemont, J., Ngandu, T., Beishuizen, C., Coley, N., Brayne, C., Andrieu, S., Richard, E., Soininen, H., and Kivipelto, M.,
“Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”,
J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D.,
“Detecting At-Risk Alzheimer's Disease Cases.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D.,
“Detecting At-Risk Alzheimer's Disease Cases.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
H. B. Mehta, Mehta, V., Tsai, C. - L., Chen, H., Aparasu, R. R., and Johnson, M. L.,
“Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 423-32, 2016.
K. Jekel, Damian, M., Storf, H., Hausner, L., and Frölich, L.,
“Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies.”,
J Alzheimers Dis, vol. 52, no. 2, pp. 509-17, 2016.
G. Richter Vaz, Hädrich, G., Bidone, J., Rodrigues, J. Lima, Falkembach, M. Corrêa, Putaux, J. - L., Hort, M. Appel, Monserrat, J. Maria, Junior, A. Sergio Var, Teixeira, H. Ferreira, Muccillo-Baisch, A. Luiza, Horn, A. Paula, and Dora, C. Lima,
“Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting.”,
J Alzheimers Dis, vol. 59, no. 3, pp. 961-974, 2017.
G. M. McKhann, Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H.,
“The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”,
Alzheimers Dement, vol. 7, no. 3, pp. 263-9, 2011.
M. S. Albert, DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., and Phelps, C. H.,
“The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”,
Alzheimers Dement, vol. 7, no. 3, pp. 270-9, 2011.
W. J. Jansen, Handels, R. L. H., Visser, P. Jelle, Aalten, P., Bouwman, F., Claassen, J., van Domburg, P., Hoff, E., Hoogmoed, J., Leentjens, A. F. G., Rikkert, M. Olde, Oleksik, A. M., Smid, M., Scheltens, P., Wolfs, C., Verhey, F., and Ramakers, I. H. G. B.,
“The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F.,
“Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
J. Krämer, Lueg, G., Schiffler, P., Vrachimis, A., Weckesser, M., Wenning, C., Pawlowski, M., Johnen, A., Teuber, A., Wersching, H., Meuth, S. G., and Duning, T.,
“Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.”,
J Alzheimers Dis, vol. 63, no. 1, pp. 239-253, 2018.
L. Zhang, Sun, C., Jin, Y., Gao, K., Shi, X., Qiu, W., Ma, C., and Zhang, L.,
“Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 60, no. 2, pp. 733-746, 2017.
L. Shi, Winchester, L. M., Liu, B. Y., Killick, R., Ribe, E. M., Westwood, S., Baird, A. L., Buckley, N. J., Hong, S., Dobricic, V., Kilpert, F., Franke, A., Kiddle, S., Sattlecker, M., Dobson, R., Cuadrado, A., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Kate, M. Ten, Scheltens, P., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Alcolea, D., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Teunissen, C. E., Freund-Levi, Y., Frölich, L., Legido-Quigley, C., Barkhof, F., Blennow, K., Rasmussen, K. Laura, Nordestgaard, B. Grønne, Frikke-Schmidt, R., Nielsen, S. Fallgaard, Soininen, H., Vellas, B., Kloszewska, I., Mecocci, P., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, Bertram, L., Nevado-Holgado, A. J., and Lovestone, S.,
“Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
L. Yu, Wang, W., Pang, W., Xiao, Z., Jiang, Y., and Hong, Y.,
“Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 475-482, 2017.
C. R. Beam, Kaneshiro, C., Jang, J. Yun, Reynolds, C. A., Pedersen, N. L., and Gatz, M.,
“Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1077-1083, 2018.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D.,
“Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”,
J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S.,
“Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
S. Wolfsgruber, Kleineidam, L., Wagner, M., Mösch, E., Bickel, H., Lϋhmann, D., Ernst, A., Wiese, B., Steinmann, S., König, H. - H., Brettschneider, C., Luck, T., Stein, J., Weyerer, S., Werle, J., Pentzek, M., Fuchs, A., Maier, W., Scherer, M., Riedel-Heller, S. G., and Jessen, F.,
“Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.”,
J Alzheimers Dis, vol. 54, no. 3, pp. 1135-1146, 2016.
E. L. Abner, Neltner, J. H., Jicha, G. A., Patel, E., Anderson, S. L., Wilcock, D. M., Van Eldik, L. J., and Nelson, P. T.,
“Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1307-1324, 2018.
B. Li, Xu, P., Wu, S., Jiang, Z., Huang, Z., Li, Q., and Chen, D.,
“Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting the TLR/NF-κB Pathway.”,
J Alzheimers Dis, vol. 64, no. 3, pp. 943-955, 2018.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J.,
“Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo.”,
J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W.,
“Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.
] Type Year 